Markets experienced volatility, ending nearly flat as participants adopted a cautious stance amid global headwinds. Key companies like Lenskart, Trent, and Bajaj Auto reported their second-quarter results, with Lenskart set for its exchange debut. Several other firms, including Adani Enterprises and TVS Motor, are also in focus due to business developments and expansion plans.Read More

Goldman Sachs has upgraded Indian equities to ‘overweight’ with a 2026 Nifty target of 29,000, anticipating a strong rebound after this year’s underperformance. The brokerage cited stabilizing earnings and expected policy easing as key drivers.Read More

India’s short-term debt markets saw a surge in September as corporates ramped up commercial paper issuances to ₹62,300 crore for festive season liquidity. Banks, particularly public sector lenders, aggressively tapped the certificate of deposit market, raising ₹1.04 lakh crore. NBFCs, however, adopted a more measured approach, moderating their CP issuances.Read More

The Reserve Bank of India has reportedly urged state governments to postpone bond auctions to alleviate supply pressure in a saturated market. This move aims to ease competition with key sovereign securities, with a significant portion of state development loans potentially deferred until the fiscal year’s end. The central bank signaled this plan during a...Read More

Nifty is showing signs of ending its correction, with strong support identified between 25,200-25,300. Analysts suggest a move above 25,550 could revive the uptrend towards 26,000, while a break below 25,000 might extend the decline. Traders are advised to consider buy-on-dips strategies.Read More

InCred Holdings, the parent company of InCred Finance, has submitted a confidential draft to the Securities & Exchange Board of India for an initial public offering. The company plans to raise between ₹3,000 to ₹4,000 crore through this IPO. InCred Finance has a significant track record, having disbursed over ₹25,000 crore in loans.Read More

Lenskart Solutions is set for a modest stock market debut on Monday. Analysts suggest investors who received allotments can book profits upon listing. The grey market premium has declined significantly. Experts recommend exiting the stock even with small gains. The IPO saw strong subscription across investor categories, particularly from qualified institutional buyers.Read More

Sun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launches and pipeline advancements, including Unloxcyt and Leqselvi, are poised to drive long-term growth. Analysts maintain a ‘BUY’ rating, anticipating an 11-18% upside.Read More

US economy remains strong despite tariffs, according to Sonal Desai. India’s economy is also resilient. The Federal Reserve may not cut interest rates as much as markets expect. Gold reflects global uncertainty and belief in medium-term inflation. Investors might consider emerging markets like India for diversification. The fiscal outlook for developed nations is a significant...Read More

Indian markets closed lower amidst weekly volatility, with slight sentiment improvement following positive US-India trade talk indications. Analysts anticipate range-bound trading next week, influenced by mixed global cues, but corporate earnings and trade progress could offer support.Read More